Phathom Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.

About PHAT

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

CEO

Steven L. Basta

CEOSteven L. Basta

Employees

427

Employees427

Headquarters

Florham Park, New Jersey

HeadquartersFlorham Park, New Jersey

Founded

2018

Founded2018

Employees

427

Employees427

PHAT Key Statistics

Market cap

974.15M

Market cap974.15M

Price-Earnings ratio

-2.86

Price-Earnings ratio-2.86

Dividend yield

—

Dividend yield—

Average volume

1.03M

Average volume1.03M

High today

$14.09

High today$14.09

Low today

$13.56

Low today$13.56

Open price

$13.65

Open price$13.65

Volume

155.98K

Volume155.98K

52 Week high

$19.50

52 Week high$19.50

52 Week low

$2.21

52 Week low$2.21

PHAT News

TipRanks 4h

Phathom Pharmaceuticals Publishes Phase 3 Trial Results

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own PHAT. This list is generated using Robinhood data, and it’s not a recommendation.